Icon

CADUET (nda021540)- (EQ 5MG BASE;EQ 10MG BASE,EQ 5MG BASE;EQ 20MG BASE,EQ 5MG BASE;EQ 40MG BASE,EQ 5MG BASE;EQ 80MG BASE,EQ 10MG BASE;EQ 10MG BASE,EQ 10MG BASE;EQ 20MG BASE,EQ 10MG BASE;EQ 40MG BASE,EQ 10MG BASE;EQ 80MG BASE,EQ 2.5MG BASE;EQ 10MG BASE,EQ 2.5MG BASE;EQ 20MG BASE,EQ 2.5MG BASE;EQ 40MG BASE)

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM PHARMACIA
EQ 5MG BASE;EQ 10MG BASE,EQ 5MG BASE;EQ 20MG BASE,EQ 5MG BASE;EQ 40MG BASE,EQ 5MG BASE;EQ 80MG BASE,EQ 10MG BASE;EQ 10MG BASE,EQ 10MG BASE;EQ 20MG BASE,EQ 10MG BASE;EQ 40MG BASE,EQ 10MG BASE;EQ 80MG BASE,EQ 2.5MG BASE;EQ 10MG BASE,EQ 2.5MG BASE;EQ 20MG BASE,EQ 2.5MG BASE;EQ 40MG BASE
Yes No
2018-Aug-11 Expired
None None
None No
CADUET is a combination of amlodipine besylate, a calcium channel blocker, and atorvastatin calcium, a HMG CoA-reductase inhibitor, indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. Amlodipine is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Amlodipine is indicated for the treatment of Coronary Artery Disease. Atorvastatin is indicated as an adjunct therapy to diet for prevention of cardiovascular disease and hyperlipidemia.
4 0 4
Total Other Developers 2
Drugs with Suitability No
EQ 5MG BASE;EQ 10MG BASE ** ** Up - 2
EQ 5MG BASE;EQ 20MG BASE ** ** Down - 2
EQ 5MG BASE;EQ 40MG BASE ** ** Up - 2
EQ 5MG BASE;EQ 80MG BASE ** ** - - 2
EQ 10MG BASE;EQ 10MG BASE ** ** Up - 2
EQ 10MG BASE;EQ 20MG BASE ** ** Up - 2
EQ 10MG BASE;EQ 40MG BASE ** ** Up - 2
EQ 10MG BASE;EQ 80MG BASE ** ** Down - 2
EQ 2.5MG BASE;EQ 10MG BASE ** ** - - -
EQ 2.5MG BASE;EQ 20MG BASE ** ** - - -
EQ 2.5MG BASE;EQ 40MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ****** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.